Ashfield Capital Partners LLC trimmed its holdings in shares of Danaher Co. (NYSE:DHR) by 5.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 95,533 shares of the conglomerate’s stock after selling 5,107 shares during the quarter. Danaher accounts for about 1.1% of Ashfield Capital Partners LLC’s investment portfolio, making the stock its 25th biggest position. Ashfield Capital Partners LLC’s holdings in Danaher were worth $8,867,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Honeywell International Inc. increased its position in shares of Danaher by 113.4% during the third quarter. Honeywell International Inc. now owns 640,100 shares of the conglomerate’s stock worth $54,908,000 after acquiring an additional 340,100 shares during the last quarter. Progressive Investment Management Corp increased its position in shares of Danaher by 5.9% during the fourth quarter. Progressive Investment Management Corp now owns 37,108 shares of the conglomerate’s stock worth $3,444,000 after acquiring an additional 2,074 shares during the last quarter. Hikari Tsushin Inc. increased its position in shares of Danaher by 8.9% during the second quarter. Hikari Tsushin Inc. now owns 65,135 shares of the conglomerate’s stock worth $5,497,000 after acquiring an additional 5,300 shares during the last quarter. Point72 Asset Management L.P. increased its position in shares of Danaher by 276.8% during the third quarter. Point72 Asset Management L.P. now owns 2,626,865 shares of the conglomerate’s stock worth $225,332,000 after acquiring an additional 1,929,751 shares during the last quarter. Finally, Prudential Financial Inc. increased its position in shares of Danaher by 5.2% during the third quarter. Prudential Financial Inc. now owns 2,628,584 shares of the conglomerate’s stock worth $225,480,000 after acquiring an additional 130,621 shares during the last quarter. 77.05% of the stock is currently owned by institutional investors and hedge funds.
Danaher Co. (NYSE DHR) opened at $99.57 on Wednesday. The company has a market capitalization of $69,460.00, a PE ratio of 28.45, a P/E/G ratio of 2.09 and a beta of 1.04. Danaher Co. has a 52 week low of $78.97 and a 52 week high of $104.82. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, March 29th will be paid a $0.16 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date is Wednesday, March 28th. Danaher’s payout ratio is presently 16.00%.
In other Danaher news, insider Rainer Blair sold 51,080 shares of Danaher stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $97.26, for a total value of $4,968,040.80. Following the completion of the transaction, the insider now directly owns 50,477 shares in the company, valued at $4,909,393.02. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Angela S. Lalor sold 42,988 shares of Danaher stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $102.29, for a total value of $4,397,242.52. Following the completion of the transaction, the senior vice president now owns 82,008 shares of the company’s stock, valued at $8,388,598.32. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 313,260 shares of company stock valued at $31,657,786. 12.20% of the stock is currently owned by insiders.
A number of analysts have recently issued reports on the company. Barclays assumed coverage on Danaher in a research report on Thursday, February 15th. They set an “overweight” rating and a $110.00 target price on the stock. Credit Suisse Group lifted their target price on Danaher from $99.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Stifel Nicolaus reaffirmed a “buy” rating and set a $110.00 target price on shares of Danaher in a research report on Friday, January 19th. Royal Bank of Canada reaffirmed a “hold” rating and set a $98.00 target price on shares of Danaher in a research report on Wednesday, January 31st. Finally, Morgan Stanley lifted their target price on Danaher from $103.00 to $110.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 31st. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $100.68.
ILLEGAL ACTIVITY NOTICE: “Ashfield Capital Partners LLC Cuts Holdings in Danaher Co. (DHR)” was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3227266/ashfield-capital-partners-llc-cuts-holdings-in-danaher-co-dhr.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.